共 50 条
- [1] Trueman P(1999)Prevalence of lower urinary tract symptoms and self-reported diagnosed “benign prostatic hyperplasia”, and their effect on quality of life in a community-based survey of men in the UK BJU Int 83 410-415
- [2] Hood SC(2007)Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting Int J Clin Pract 61 1437-1445
- [3] Nayak US(1999)Is transurethral resection of the prostate still justified? BJU Int 83 227-237
- [4] Naslund MJ(2011)Update on AUA guideline on the management of benign prostatic hyperplasia J Urol 185 1793-1803
- [5] Gilsenan AW(2008)Treatment options for benign prostatic hyperplasia in older men Med Sci Monit Int Med J Exp Clin Res 14 RA94-R102
- [6] Midkiff KD(2006)Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention Eur Urol 50 969-979
- [7] Madersbacher S(2006)Safety and tolerability of treatment for BPH Eur Urol Suppl 5 1004-1012
- [8] Marberger M(1996)The effect of prostatectomy on symptom severity and quality of life Br J Urol 77 233-247
- [9] McVary KT(2018)WATER: a double-blind, randomized, controlled trial of Aquablation® vs transurethral resection of the prostate in benign prostatic hyperplasia J Urol 199 1252-1261
- [10] Roehrborn CG(1992)The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association J Urol 148 1549-1557